The post Sonic Labs passes proposal to expand to U.S. capital markets appeared on BitcoinEthereumNews.com. Sonic Labs, the team behind the high-performance Layer-1 blockchain that evolved from Fantom, has secured overwhelming community approval for its first major governance proposal.  Summary Sonic Labs’ governance approved a $150M issuance to fund U.S. market expansion. The plan includes an ETF, NASDAQ PIPE, and launch of Sonic USA LLC in New York. New tokenomics introduce stronger burn mechanisms to counter dilution risks. The proposal, officially passed on Aug. 31, paves the way for the project’s expansion into the U.S. capital markets through new financial products, institutional partnerships, and a dedicated American entity. A landmark governance vote The vote, conducted on Snapshot from Aug. 20 to Aug. 31, attracted significant participation from Sonic’s community. Nearly 860 million S (S) tokens, well over the 700 million required for a quorum, were cast in favor of the proposal, which received 99.99% approval. The outcome authorizes Sonic Labs to issue $150 million worth of new $S tokens to fund its expansion. Allocations include $50 million to back a U.S.-listed exchange-traded product (ETP/ETF), $100 million to support a NASDAQ private investment in public equity vehicle, and 150 million tokens earmarked for the launch of Sonic USA LLC. The Delaware-based subsidiary will establish a New York office and hire a U.S.-based CEO alongside a capital markets and business development team. From tokenomics constraints to U.S. expansion The initiative comes as Sonic addresses long-standing challenges from its origins as Fantom. Unlike many rival blockchains that retained up to 80% of their token supply, Fantom, and later Sonic, held just 3% after a community-led takeover. As a result, Sonic had limited treasury flexibility, which hindered its ability to seek capital market opportunities, partnerships, and listings.  Sonic Labs argued that modern tokenomics were necessary to compete. The project can now add deflationary mechanisms to balance supply and facilitate… The post Sonic Labs passes proposal to expand to U.S. capital markets appeared on BitcoinEthereumNews.com. Sonic Labs, the team behind the high-performance Layer-1 blockchain that evolved from Fantom, has secured overwhelming community approval for its first major governance proposal.  Summary Sonic Labs’ governance approved a $150M issuance to fund U.S. market expansion. The plan includes an ETF, NASDAQ PIPE, and launch of Sonic USA LLC in New York. New tokenomics introduce stronger burn mechanisms to counter dilution risks. The proposal, officially passed on Aug. 31, paves the way for the project’s expansion into the U.S. capital markets through new financial products, institutional partnerships, and a dedicated American entity. A landmark governance vote The vote, conducted on Snapshot from Aug. 20 to Aug. 31, attracted significant participation from Sonic’s community. Nearly 860 million S (S) tokens, well over the 700 million required for a quorum, were cast in favor of the proposal, which received 99.99% approval. The outcome authorizes Sonic Labs to issue $150 million worth of new $S tokens to fund its expansion. Allocations include $50 million to back a U.S.-listed exchange-traded product (ETP/ETF), $100 million to support a NASDAQ private investment in public equity vehicle, and 150 million tokens earmarked for the launch of Sonic USA LLC. The Delaware-based subsidiary will establish a New York office and hire a U.S.-based CEO alongside a capital markets and business development team. From tokenomics constraints to U.S. expansion The initiative comes as Sonic addresses long-standing challenges from its origins as Fantom. Unlike many rival blockchains that retained up to 80% of their token supply, Fantom, and later Sonic, held just 3% after a community-led takeover. As a result, Sonic had limited treasury flexibility, which hindered its ability to seek capital market opportunities, partnerships, and listings.  Sonic Labs argued that modern tokenomics were necessary to compete. The project can now add deflationary mechanisms to balance supply and facilitate…

Sonic Labs passes proposal to expand to U.S. capital markets

Sonic Labs, the team behind the high-performance Layer-1 blockchain that evolved from Fantom, has secured overwhelming community approval for its first major governance proposal. 

Summary

  • Sonic Labs’ governance approved a $150M issuance to fund U.S. market expansion.
  • The plan includes an ETF, NASDAQ PIPE, and launch of Sonic USA LLC in New York.
  • New tokenomics introduce stronger burn mechanisms to counter dilution risks.

The proposal, officially passed on Aug. 31, paves the way for the project’s expansion into the U.S. capital markets through new financial products, institutional partnerships, and a dedicated American entity.

A landmark governance vote

The vote, conducted on Snapshot from Aug. 20 to Aug. 31, attracted significant participation from Sonic’s community. Nearly 860 million S (S) tokens, well over the 700 million required for a quorum, were cast in favor of the proposal, which received 99.99% approval.

The outcome authorizes Sonic Labs to issue $150 million worth of new $S tokens to fund its expansion. Allocations include $50 million to back a U.S.-listed exchange-traded product (ETP/ETF), $100 million to support a NASDAQ private investment in public equity vehicle, and 150 million tokens earmarked for the launch of Sonic USA LLC.

The Delaware-based subsidiary will establish a New York office and hire a U.S.-based CEO alongside a capital markets and business development team.

From tokenomics constraints to U.S. expansion

The initiative comes as Sonic addresses long-standing challenges from its origins as Fantom. Unlike many rival blockchains that retained up to 80% of their token supply, Fantom, and later Sonic, held just 3% after a community-led takeover. As a result, Sonic had limited treasury flexibility, which hindered its ability to seek capital market opportunities, partnerships, and listings. 

Sonic Labs argued that modern tokenomics were necessary to compete. The project can now add deflationary mechanisms to balance supply and facilitate institutional adoption by generating reserves through the new issuance. The approved changes may increase long-term token scarcity by burning a larger portion of network gas fees. 

Sonic is positioned to bridge the gap between traditional and decentralized finance thanks to the U.S. initiative. Plans include partnering with a top-tier ETF provider and BitGo for custody to create a regulated investment vehicle. At the same time, the PIPE allocation aims to align Sonic with NASDAQ-listed companies that share long-term conviction in its growth.

The establishment of Sonic USA is expected to hasten S adoption in traditional finance, regulatory alignment, and institutional engagement. 

Source: https://crypto.news/sonic-labs-passes-proposal-u-s-capital-markets-2025/

Market Opportunity
Sonic SVM Logo
Sonic SVM Price(SONIC)
$0.07336
$0.07336$0.07336
-0.38%
USD
Sonic SVM (SONIC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26